Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 1, 2003, Pages 29-44

  Dulk, Marcel Den ^a,b   Bishop, G Alex ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

Graft rejection; Graft survival; Immunosuppressive agents; Liver transplantation; Transplantation tolerance

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN;

CELL MATURATION; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; RECIPIENT; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULARIZATION;

ANIMALS; GENES, MHC CLASS I; GRAFT REJECTION; GRAFT SURVIVAL; HLA-A ANTIGENS; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; RATS; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA;

EID: 0037275732     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med., 187, 1555-1564.
2. AFFORD S. C., HUBSCHER S., STRAIN A. J., ADAMS D. H. and NEUBERGER J. M. (1995): Apoptosis in the human liver during allograft rejection and end-stage liver disease. J. Pathol., 176, 373-380.
3. ALLISON A. C. (2000): Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology, 47, 63-83.
4. BANCHEREAU J. and STEINMAN R. M. (1998): Dendritic cells and the control of immunity. Nature, 392, 245-252.
5. BERGESE S. D., KLENOTIC S. M., WAKELY M. E., SEDMAK D. D. and OROSZ C. G. (1997): Apoptosis in murine cardiac grafts. Transplantation, 63, 320-325.
6. BERTOLINO P., KLIMPEL G. and LEMON S. M. (2000): Hepatic inflammation and immunity: a summary of a conference on the function of the immune system within the liver. Hepatology, 31, 1374-1378.
7. BERTOLINO P., MCCAUGHAN G. W. and BOWEN D. G. (2002): Role of primary intrahepatic T-cell activation in the "liver tolerance effect". Immunol. Cell Biol., 80, 84-92.
8. + T lymphocytes but fail to promote survival. Eur. J. Immunol., 28, 221-236.
9. BERTOLINO P., TRESCOL-BIEMONT M. C., THOMAS J., FAZEKAS DE ST GROTH B., PIHLGREN M., MARVEL J. and RABOURDIN-COMBe C. (1999): Death by neglect as a deletional mechanism of peripheral tolerance. Int. Immunol., 11, 1225-1238.
10. BICKERSTAFF A. A., WANG J. J., PELLETIER R. P. and OROSZ C. G. (2001): Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J. Immunol., 167, 4821-4827.
11. BISHOP G. A., SUN J., DECRUZ D. J., ROKAHR K. L., SEDGWICK J. D., SHEIL A. G., GALLAGHER N. D. and MCCAUGHAN G. W. (1996): Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J. Immunol., 156, 4925-4931.
12. BITTER-SUERMANN H. (1974): Survival of unmodified spleen allografts in rats. Nature, 247, 465-466.
13. BITTER-SUERMANN H. and SAVE-SODERBERGH J. (1978): The course of pancreas allografts in rats conditioned by spleen allografts. Transplantation, 26, 28-34.
14. BONHAM C. A., LU L., LI Y., HOFFMAN R. A., SIMMONS R. L. and THOMSON A. W. (1996): Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses. Transplantation, 62, 1871-1877.
15. BRENNAN D. C., MOHANAKUMAR T. and FLYE M. W. (1995): Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms. Am. J. Kid. Dis., 26, 701-705.
16. BRENT L. and GOWLAND G. (1962): Induction of tolerance of skin homografts in immunologically competent mice. Nature, 196, 1298-1301.
17. BUELENS C., VERHASSELT V., DE GROOTE D., THIELEMANS K., GOLDMAN M. and WILLEMS F. (1997): Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol., 27, 1848-1852.
18. BUMGARDNER G. L., MATAS A. J., CHEN S., CAHILL D., CUNNINGHAM T. R., PAYNE W. D., BACH F. H. and ASCHER N. L. (1990): Comparison of in vivo and in vitro immune response to purified hepatocytes. Transplantation, 49, 429-436.
19. CALNE R. (1996): WOFIE hypothesis: some thoughts on an approach toward allograft tolerance. Transplant. Proc., 28, 1152.
20. CALNE R. Y., SELLS R. A., PENA J. R., DAVIS D. R., MILLARD P. R., HERBERTSON B. M., BINNS R. M. and DAVIES D. A. (1969): Induction of immunological tolerance by porcine liver allografts. Nature, 223, 472-476.
21. CECKA J. M. (1999): The UNOS Scientific Renal Transplant Registry. Clin. Transpl., 1-21.
22. CHIBA S., GOTO S., SHIMIZU Y., VARI F., LORD R., EDWARDS-SMITH C., KOBAYASHI S., OCHIAI T. and ISONO K. (1997): The characterization of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation. Transpl. Int., 10, 350-356.
23. CRISPE I. N. and MEHAL W. Z. (1996): Strange brew: T cells in the liver. Immunol. Today, 17, 522-525.
24. DAVIES H. S., KAMADA N. and ROSER B. J. (1983): Mechanisms of donor specific unresponsiveness induced by liver grafting. Transplant. Proc., 15, 831-835.
25. DAVIES H. S., POLLARD S. G. and CALNE R. Y. (1989): Soluble HLA antigens in the circulation of liver graft recipients. Transplantation, 47, 524-527.
26. DELRIVIERE L., HAVAUX X., LATINNE D., BAZIN H., KAMADA N., NORDLINGER B. and GIANELLO P. (1997): Administration of exogenous interleukin-2 abrogates spontaneous rat liver allograft acceptance but does not affect long-established graft survival. Transplantation, 63, 1698-1701.
27. DEVLIN J. J., LEW A. M., FLAVELL R. A. and COLIGAN J. E. (1985): Secretion of a soluble class I molecule encoded by the Q10 gene of the C57BL/10 mouse. EMBO J., 4, 369-374.
28. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol., 163, 2314-2321.
29. DORAN T. J., GECZY A. F., PAINTER D., MCCAUGHAN G., SHEIL A. G., SUSAL C. and OPELZ G. (2000): Large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation, 69, 1491-1498.
30. DRAKES M. L., LU L., SUBBOTIN V. M. and THOMSON A. W. (1997): In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J. Immunol., 159, 4268-4278.
31. DRESSKE B., ZAVAZAVA N., HUANG D. S., LIN X., KREMER B. and FANDRICH F. (1998): WOFIE augments the immunosuppressive potency of FK-506. Transpl. Immunol., 6, 243-249.
32. DUKE R. C. and COHEN J. J. (1986): IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res., 5, 289-299.
33. FEHSEL K., KRONCKE K. D., MEYER K. L., HUBER H., WAHN V. and KOLB-BACHOFEN V. (1995): Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol., 155, 2858-2865.
34. FINKELMAN F. D., LEES A., BIRNBAUM R., GAUSE W. C. and MORRIS S. C. (1996): Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol., 157, 1406-1414.
35. FLYE M. W., RODGERS G., KACY S., MAYSCHAK D. M. and THORPE L. (1983): Prevention of fatal rejection of SLA-mismatched orthotopic liver allografts in inbred miniature swine by cyclosporin-A. Transplant. Proc., 15, 1269-1271.
36. FONTES P., RAO A. S., DEMETRIS A. J., ZEEVI A., TRUCCO M., CARROLL P., RYBKA W., RUDERT W. A., RICORDI C., DODSON F. et al. (1994): Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet, 344, 151-155.
37. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation, 62, 659-665.
38. GIANELLO P. R. and SACHS D. H. (1996): Effect of major histocompatibility complex matching on the development of tolerance to primarily vascularized renal allografts: a study in miniature swine. Hum. Immunol., 50, 1-10.
39. GRACIE J. A., BOLTON E. M., PORTEOUS C. and BRADLEY J. A. (1990): T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J. Exp. Med., 172, 1547-1557.
40. HALL B. M. (1991): Cells mediating allograft rejection. Transplantation, 51, 1141-1151.
41. HAMMOND K. J., POULTON L. D., PALMISANO L. J., SILVEIRA P. A., GODFREY D. I. and BAXTER A. G. (1998): α/β-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med., 187, 1047-1056.
42. HARIHARAN S., JOHNSON C. P., BRESNAHAN B. A., TARANTO S. E., MCINTOSH M. J. and STABLEIN D. (2000): Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med., 342, 605-612.
43. HAYAMIZU K., HUIE P., SIBLEY R. K. and STROBER S. (1998): Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation, 66, 1285-1291.
44. HAYASHI A., ITO H., SHOMORI K., OHDAN H., YANO K. and ASAHARA T. (1997): Frequent occurrence of hepatocytic apoptosis in acute rejection of the grafted rat liver. Pathol. Int., 47, 518-524.
45. HIBBERD A. D. and SCOTT L. J. (1983): Allogeneic platelets increase the survival of rat renal allografts. Transplantation, 35, 622-624.
46. HOSENPUD J. D., BENNETT L. E., KECK B. M., BOUCEK M. M. and NOVICK R. J. (2001): The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report 2001. J. Heart Lung Transplant., 20, 805-815.
47. HUANG L., SOLDEVILA G., LEEKER M., FLAVELL R. and CRISPE I. N. (1994): The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity, 1, 741-749.
48. HUANG W. H., YAN Y., DE BOER B., BISHOP G. A. and HOUSE A. K. (2003): A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Transplantation (in press).
49. HUANG W. H., YAN Y., DE BOER B., HOUSE A. K. and BISHOP G. A. (2001): Effect of cyclosporine and mycophenolate on rat liver transplant tolerance and rejection. Immunol. Cell Biol., 79, A9.
50. ISHIZAKA S., SAITO S., YOSHIKAWA M., KIMOTO M. and NISHIYAMA T. (1996): IL-10 production in mouse hepatocytes augmented by TGF-β. Cytokine, 8, 837-843.
51. JACOBSEN I. M. and CLAESSON M. H. (1998): Veto cell suppression mechanisms in the prevention of allograft rejection. APMIS, 106, 345-353.
52. KAMADA N. (1985): The immunology of experimental liver transplantation in the rat. Immunology, 55, 369-389.
53. KAMADA N., BRONS G. and DAVIES H. S. (1980): Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation, 29, 429-431.
54. KAMADA N., DAVIES H. S. and ROSER B. (1981): Reversal of transplantation immunity by liver grafting. Nature, 292, 840-842.
55. KAMADA N. and SHINOMIYA T. (1985): Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology, 55, 85-90.
56. KAMADA N., TERAMOTO K., BAGUERIZO A., ISHIKAWA M., SUMIMOTO R. and OHKOUCHI Y. (1988): Cellular basis of transplantation tolerance induced by liver grafting in the rat. Extent of clonal deletion among thoracic duct lymphocytes, spleen and lymph node cells. Transplantation, 46, 165-167.
57. KAMADA N. and WIGHT D. G. (1984): Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation, 38, 217-221.
58. KHOURY S. J., GALLON L., CHEN W., BETRES K., RUSSELL M. E., HANCOCK W. W., CARPENTER C. B., SAYEGH M. H. and WEINER H. L. (1995): Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med., 182, 357-366.
59. KNECHTLE S. J., WOLFE J. A., BURCHETTE J., SANFILIPPO F. and BOLLINGER R. R. (1987): Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. Transplantation, 43, 169-172.
60. KO S., DEIWICK A., JAGER M. D., DINKEL A., ROHDE F., FISCHER R., TSUI T. Y., RITTMANN K. L., WONIGEIT K. and SCHLITT H. J. (1999): The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat. Med., 5, 1292-1297.
61. KRAMS S. M., EGAWA H., QUINN M. B., VILLANUEVA J. C., GARCIA-KENNEDY R. and MARTINEZ O. M. (1995): Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation, 59, 621-625.
62. KUBIT V., SONMEZ-ALPAN E., ZEEVI A., PARADIS I., DAUBER J. H., IACONO A., KEENAN R., GRIFFITH B. P. and YOUSEM S. A. (1994): Mixed allogeneic chimerism in lung allograft recipients. Hum. Pathol., 25, 408-412.
63. LOWRY R. P., TAKEUCHI T., CREMISI H. and KONIECZNY B. (1993): Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance. Transplant. Proc., 25, 324-326.
64. LU L., BONHAM C. A., CHAMBERS F. G., WATKINS S. C., HOFFMAN R. A., SIMMONS R. L. and THOMSON A. W. (1996): Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol., 157, 3577-3586.
65. LU L., LI W., ZHONG C. P., QIAN S., FUNG J. J., THOMSON A. W. and STARZL T. E. (1999): Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation, 68, 747-757.
66. +, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation, 60, 1539-1545.
67. LU L., QIAN S., HERSHBERGER P. A., RUDERT W. A., LYNCH D. H. and THOMSON A. W. (1997): Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol., 158, 5676-5684.
68. LUTZ M. B., SURI R. M., NIIMI M., OGILVIE A. L., KUKUTSCH N. A., ROSSNER S., SCHULER G. and AUSTYN J. M. (2000): Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol., 30, 1813-1822.
69. + T cell receptor-α/β+ cells: new clues to their origin, specificity, and function. J. Exp. Med., 182, 633-638.
70. MACKAY C. R., MARSTON W. L. and DUDLER L. (1990): Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med., 171, 801-817.
71. MADSEN J. C., SUPERINA R. A., WOOD K. J. and MORRIS P. J. (1988): Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature, 332, 161-164.
72. MANN D. W., STROYNOWSKI I., HOOD L. and FORMAN J. (1987): Cytotoxic T lymphocytes from mice with soluble class I Q10 molecules in their serum are not tolerant to membrane-bound Q10. J. Immunol., 138, 240-245.
73. MANNING D. D., REED N. D. and SHAFFER C. F. (1973): Maintenance of skin xenografts of widely divergent phylogenetic origin by congenitally athymic (nude) mice. J. Exp. Med., 138, 488-494.
74. MARGULIES D. H., RAMSEY A. L., BOYD L. F. and MCCLUSKEY J. (1986): Genetic engineering of an H-2Dd/Q10b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants. Proc. Natl. Acad. Sci. USA, 83, 5252-5256.
75. MARTIN D. R., SHENG-TANNER X. and MILLER R. G. (1992): Rapid and long-term changes to host cytotoxic T lymphocyte precursors reactive to donor antigens caused by intravenous injection of histoincompatible lymphocytes. Transplantation, 54, 125-129.
76. MCCAUGHAN G. W. (2002): Withdrawal of immunosuppression in liver transplant recipients: is this as good as it gets? Liver Transpl., 8, 408-410.
77. MORELLI A. E., O'CONNELL P. J., KHANNA A., LOGAR A. J., LU L. and THOMSON A. W. (2000): Preferential induction of Th1 responses by functionally mature hepatic (CD8α-and CD8α+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation, 69, 2647-2657.
78. MORRIS P. J., WOOD K. J. and DALLMAN M. J. (1991): Antigen-induced tolerance to organ allografts. Ann. N. Y. Acad. Sci., 636, 295-305.
79. MOSMANN T. R. and SAD S. (1996): The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today, 17, 138-146.
80. MURASE N., KIM D. G., TODO S., CRAMER D. V., FUNG J. and STARZL T. E. (1990): FK506 suppression of heart and liver allograft rejection. II. The induction of graft acceptance in rats. Transplantation, 50, 739-744.
81. OCKNER S. A., GUTTMANN R. D. and LINDQUIST R. R. (1970): Renal transplantation in the inbred rat XIII. Modification of rejection by active immunization with bone marrow cells. Transplantation, 9, 30-38.
82. OLVER S., GOTO S., CHIBA S., CLOUSTON A. and KELSO A. (1998): Persistence of donor-reactive CD4 cells in liver and spleen of rats tolerant to a liver allograft. Transplantation, 66, 132-135.
83. OPELZ G. (1995): Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative Transplant Study. Transplantation, 60, 1220-1224.
84. PARK S., MURRAY D., JOHN B. and CRISPE I. N. (2002): Biology and significance of T-cell apoptosis in the liver. Immunol. Cell Biol., 80, 74-83.
85. PESCOVITZ M. D., THISTLETHWAITE J. R. JR., AUCHINCLOSS H. JR. ILDSTAD S. T., SHARP T. G., TERRILL R. and SACHS D. H. (1984): Effect of class II antigen matching on renal allograft survival in miniature swine. J. Exp. Med., 160, 1495-1508.
86. POURSHADI M., DE FAZIO S. R. and GOZZO J. J. (1993): Abrogation of secondary skin allograft rejection by veto-like cells in donor bone marrow. Transplantation, 56, 385-390.
87. PRIESTLEY C. A., DALCHAU R., SAWYER G. J. and FABRE J. W. (1989): A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation, 48, 1031-1038.
88. QIAN S., DEMETRIS A. J., MURASE N., RAO A. S., FUNG J. J. and STARZL T. E. (1994): Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology, 19, 916-924.
89. QIAN S., FU F., LI Y., LU L., RAO A. S., STARZL T. E., THOMSON A. W. and FUNG J. J. (1996): Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology, 88, 124-129.
90. QIAN S., FUNG J. J., DEMETRIS A. J., ILDSTAD S. T. and STARZL T. E. (1991): Orthotopic liver transplantation in the mouse. Transplantation, 52, 562-564.
91. QIAN S., LU L., FU F., LI Y., LI W., STARZL T. E., FUNG J. J. and THOMSON A. W. (1997): Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J, Immunol., 158, 4654-4661.
92. RAMOS H. C., REYES J., ABU-ELMAGD K., ZEEVI A., REINSMOEN N., TZAKIS A., DEMETRIS A. J., FUNG J. J., FLYNN B., MCMICHAEL J. et al. (1995): Weaning of immunosuppression in long-term liver transplant recipients. Transplantation, 59, 212-217.
93. RASTELLINI C., LU L., RICORDI C., STARZL T. E., RAO A. S. and THOMSON A, W. (1995): Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation, 60, 1366-1370.
94. RUSSELL P. S., CHASE C. M., COLVIN R. B. and PLATE J. M. (1978): Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J. Exp. Med., 147, 1449-1468.
95. SALGAR S. K., SHAPIRO R., DODSON F., CORRY R., MCCURRY K., ZEEVI A., PHAM S., ABU-ELMAGD K., REYES J., JORDAN M., KEENAN R., GRIFFITH B., SESKY T., OSTROWSKI L., STARZL T. E., FUNG J. J. and RAO A. S. (1999): Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J. Leukoc. Biol., 66, 310-314.
96. SALMI M. and JALKANEN S. (1997): How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv. Immunol., 64, 139-218.
97. SCHLITT H. J., HUNDRIESER J., HISANAGA M., UTHOFF K., KARCK M., ACHTELIK M., WAHLERS T., WONIGEIT K. and PICHLMAYR R. (1995): Donor-type microchimerism after heart transplantation - a dynamic process. Transplant. Proc., 27, 155-157.
98. SCHLITT H. J., HUNDRIESER J., HISANAGA M., UTHOFF K., KARCK M., WAHLERS T., WONIGEIT K. and PICHLMAYR R. (1994): Patterns of donor-type microchimerism after heart transplantation. Lancet, 343, 1469-1471.
99. SHARLAND A. F., SHASTRY S., WANG C., ROKAHR K., SUN J., SHEIL A. G., MCCAUGHAN G. W. and BISHOP G. A. (1998): Kinetics of intragraft cytokine expression, cellular infiltration and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model. Early activation and apoptosis is associated with liver graft acceptance. Transplantation, 65, 1370-1377.
100. SHARLAND A. F., YAN Y., WANG C., BOWEN D. G., SUN J., SHEIL A. G., MCCAUGHAN G. W. and BISHOP G. A. (1999): Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation, 68, 1736-1745.
101. SHIMIZU Y., GOTO S., LORD R., VARI F., EDWARDS-SMITH C., CHIBA S., SCHLECT D., BUCKLEY M., KUSANO M. and KAMADA N. (1996): Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leukocytes. Transpl. Int., 9, 593-595.
102. SIVASAI K. S., ALEVY Y. G., DUFFY B. F., BRENNAN D. C., SINGER G. G., SHENOY S., LOWELL J. A., HOWARD T. and MOHANAKUMAR T. (1997): Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation, 64, 427-432.
103. SKOSKIEWICZ M., CHASE C., WINN H. J. and RUSSELL P. S. (1973): Kidney transplants between mice of graded immunogenetic diversity. Transplant. Proc., 5, 721-725.
104. SMITH C. M., DAVIES D. B. and MCBRIDE M. A. (2000): Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network. Clin. Transpl., 19-30.
105. SPENCER S. C. and FABRE J. W. (1987): Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation, 44, 141-148.
106. SRIWATANAWONGSA V., DAVIES H. S. and CALNE R. Y. (1995): The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat. Med., 1, 428-432.
107. STARZL T. E., DEMETRIS A. J., MURASE N., ILDSTAD S., RICORDI C. and TRUCCO M. (1992): Cell migration, chimerism, and graft acceptance. Lancet, 339, 1579-1582.
108. STARZL T. E., DEMETRIS A. J., MURASE N., TRUCCO M., THOMSON A. W. and RAO A. S. (1996): The lost chord: microchimerism and allograft survival. Immunol. Today, 17, 577-584; discussion 588.
109. STARZL T. E., DEMETRIS A. J., TRUCCO M., MURASE N., RICORDI C., ILDSTAD S., RAMOS H., TODO S., TZAKIS A., FUNG J. J. et al. (1993): Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology, 17, 1127-1152.
110. STARZL T. E., DEMETRIS A. J., TRUCCO M., RAMOS H., ZEEVI A., RUDERT W. A., KOCOVA M., RICORDI C., ILDSTAD S. and MURASE N. (1992): Systemic chimerism in human female recipients of male livers. Lancet, 340, 876-877.
111. STARZL T. E., DEMETRIS A. J., TRUCCO M., ZEEVI A., RAMOS H., TERASAKI P., RUDERT W. A., KOCOVA M., RICORDI C., ILDSTAD S. et al. (1993): Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation, 55, 1272-1277.
112. STARZL T. E., MURASE N., DEMETRIS A., TRUCCO M. and FUNG J. (2000): The mystique of hepatic tolerogenicity. Semin. Liver Dis., 20, 497-510.
113. STARZL T. E. and ZINKERNAGEL R. M. (1998): Antigen localization and migration in immunity and tolerance. N. Engl. J. Med., 339, 1905-1913.
114. STEINBRINK K., WOLFL M., JONULEIT H., KNOP J. and ENK A. H. (1997): Induction of tolerance by IL-10-treated dendritic cells. J. Immunol., 159, 4772-4780.
115. STEINMAN R. M. (1991): The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
116. STEPTOE R. J., FU F., LI W., DRAKES M. L., Lu L., DEMETRIS A. J., QIAN S., MCKENNA H. J. and THOMSON A. W. (1997): Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol., 159, 5483-5491.
117. STEPTOE R. J. and THOMSON A. W. (1996): Dendritic cells and tolerance induction. Clin. Exp. Immunol., 105, 397-402.
118. SUBERBIELLE C., CAILLAT-ZUCMAN S., LEGENDRE C., BODEMER C., NOEL L. H., KREIS H. and BACH J. F. (1994): Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet, 343, 1468-1469.
119. SUMIMOTO R. and KAMADA N. (1990): Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation, 50, 678-682.
120. SUN J., MCCAUGHAN G. W., GALLAGHER N. D., SHEIL A. G. R. and BISHOP G. A. (1995): Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation, 60, 233-236.
121. SUN J., SHEIL A. G. R., WANG C., WANG L., ROKAHR K., SHARLAND A., JUNG S. E., LI L., MCCAUGHAN G. W. and BISHOP G. A. (1996): Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation, 62, 1725-1730.
122. TAKATSUKI M., UEMOTO S., INOMATA Y., EGAWA H., KIUCHI T., FUJITA S., HAYASHI M., KANEMATSU T. and TANAKA K. (2001): Weaning of immunosuppression in living donor liver transplant recipients. Transplantation, 72, 449-454.
123. TAKEMOTO S. K., TERASAKI P. I., GJERTSON D. W. and CECKA J. M. (2000): Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N. Engl. J. Med., 343, 1078-1084.
124. THAI N. L., LI Y., FU F., QIAN S., DEMETRIS A. J., DUQUESNOY R. J. and FUNG J. J. (1997): Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transplant. Surg., 3, 118-129.
125. THOMSON A. W. and Lu L. (1999): Are dendritic cells the key to liver transplant tolerance? Immunol. Today, 20, 27-32.
126. THOMSON A. W. and LU L. (1999): Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation, 68, 1-8.
127. THOMSON A. W., LU L., MURASE N., DEMETRIS A. J., RAO A. S. and STARZL T. E. (1995): Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells, 13, 622-639.
128. THOMSON A. W., O'CONNELL P. J., STEPTOE R. J. and LU L. (2002): Immunobiology of liver dendritic cells. Immunol. Cell Biol., 80, 65-73.
129. TSUI T. Y., DEIWICK A., KO S. and SCHLITT H. J. (2000): Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft-versus-host reactivity. Transplantation, 69, 25-30.
130. TSUI T. Y., JAGER M. D., DEIWICK A., ASELMANN H., NEIPP M., FAN S. T. and SCHLITT H. J. (2002): Delayed low-level calcineurin inhibition promotes allospecific tolerance induction by posttransplantation donor leukocyte infusion. Transplantation, 73, 1325-1332.
131. Tu Y. Z., ARIMA T. and FLYE M. W. (1997): Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation, 63, 177-181.
132. UCHIYAMA H., KISHIHARA K., MINAGAWA R., HASHIMOTO K., SUGIMACHI K. and NOMOTO K. (2002): Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice. Immunology, 105, 450-457.
133. VAN PARIJS L., PETERSON D. A. and ABBAS A. K. (1998): The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity, 8, 265-274.
134. VAN ROOD J. J., VAN LEEUWEN A. and VAN SANTEN M. C. (1970): Anti-HL-A2 inhibitor in normal human serum. Nature, 226, 366-367.
135. WANG C., SUN J., LI L., WANG L., DOLAN P. and SHEIL A. G. R. (1997): Conversion of pancreas allograft rejection to acceptance by liver transplantation. Transplantation, 65, 188-192.
136. WANG C., SUN J., SHEIL A. G. R., MCCAUGHAN G. W. and BISHOP G. A. (2001): A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation, 72, 44-51.
137. WIESNER R. H., BATTS K. P. and KROM R. A. F. (1999): Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transplant. Surg., 5, 388-400.
138. WOOD K. J., EVINS J. and MORRIS P. J. (1985): Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation, 39, 56-62.
139. 1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells, 15, 144-153.
140. YAN Y., SHASTRY S., RICHARDS C., WANG C., BOWEN D. G., SHARLAND A. F., PAINTER D. M., MCCAUGHAN G. W. and BISHOP G. A. (2001): Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J. Immunol., 166, 5258-5264.
141. YAN Y., VAN DER PUTTEN K., BOWEN D. G., PAINTER D. M., KOHAR J., SHARLAND A. F., MCCAUGHAN G. W. and BISHOP G. A. (2002): Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts. Transplantation, 73, 1123-1130.
142. ZAVAZAVA N. and KRONKE M. (1996): Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat. Med., 2, 1005-1010.
143. ZIMMERMANN F. A., DAVIES H. S., KNOLL P. P., GOKEL J. M. and SCHMIDT T. (1984): Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation, 37, 406-410.